Encompass Health is trading at $122.51, down 4.19%, as healthcare shares show fatigue after a defensive-led run and investors rotate back toward technology.
- Shares fell more than the healthcare ETF after recently touching a 52-week high.
- The Bangor hospital opening was described as minor near term; no clear company-specific catalyst was identified.
- Broader indices were higher, so the decline did not appear to track the market rebound. Investors are looking ahead to third-quarter results on October 28.